Ziltivekimab

1 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

Novo Nordisk halts two late‑stage heart‑failure trials of its IL‑6 drug ziltivekimab, casting doubt on its cardiovascular and kidney ambitions.

5 sources 5 articles v 3 6h ago

\n \n \n

\n \n \n \n